Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| VIASAT INC | VSAT | 19.35% |
| OLD SECOND B | OSBC | 5.76% |
| GAMCO INVEST | GBL | 4.61% |
| CORNING INC | GLW | 4.47% |
| SYNCHRONOSS | SNCR | 4.23% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Last week, Humana Inc. ( HUM - Analyst Report ) announced that it has acquired Harris, Rothenberg International Inc. The financial terms of the deal were not divulged. However, this acquisition is not likely to materially affect Humana’s 2012 financial results.
Harris Rothenberg is a 30-year old privately-held service provider that offers work/life services and employee assistance programs for a variety of issues, such as financial, legal or emotional difficulties, addiction to alcohol or drugs, child care, etc. The company also provides coaching and training to employees. Harris Rothenberg provides its services to 5.5 million people in the U.S. and 70,000 people outside the country.
The acquisition will strengthen Humana’s employee assistance programs and help its corporate clients to reduce expenditure on healthcare. It will also enable the client company to tackle problems, such as reduced productivity due to absenteeism and health problems of employees.
Earlier, in July 2012, Humana completed the acquisition of chronic-care provider SeniorBridge for an undisclosed amount. New York-based SeniorBridge is a healthcare provider, which offers in-home care to seniors with chronic diseases such as Alzheimer’s disease, Parkinson’s disease and congestive heart failure. It has a network of 1,500 care managers in the U.S.
The acquisition will expand Humana’s Health and Well Being segment, which provides primary care, pharmacy, integrated wellness, and home care services. SeniorBridge’s services will be particularly useful for Humana’s Medicare members as professional post-hospitalization home care will significantly reduce readmissions and will also ensure speedy recovery. Moreover, professional care at home will improve the general health of the old and chronically-ill members of Humana.
Earnings Review
Humana’s second-quarter 2012 operating earnings per share came in at $2.19, lagging the Zacks Consensus Estimate of $2.23 as well as the year-ago earnings of $2.59 per share. On a reported basis, Humana earned $356 million or $2.16 per share in the reported quarter, against $460 million or $2.71 per share in the prior-year quarter.
The Zacks Consensus Estimate for Humana’s third-quarter 2012 earnings stands at $2.05 per share, falling about 19% year over year. Of the 13 firms covering the stock, 12 revised their estimates downward, while no upward revisions were witnessed in the past 30 days.
Currently, the earnings for 2012 are expected to be around $7.17 per share, dipping 8% year over year. However, the estimate stands higher than Humana’s 2012 earnings forecast of $6.90–7.10 per share.
Humana Inc. is one of the largest health care plan providers in the U.S. and competes with other industry heavyweights like WellPoint Inc. ( WLP - Analyst Report ) and Aetna Inc. ( AET - Analyst Report ) . The company carries a Zacks #4 Rank, which translates into a short-term Sell rating.
Read the full Analyst Report on HUM
Read the full Analyst Report on WLP
Read the full Analyst Report on AET